- Trials with a EudraCT protocol (39)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
39 result(s) found for: Mental energy.
Displaying page 1 of 2.
EudraCT Number: 2021-003850-21 | Sponsor Protocol Number: InflaMed001 | Start Date*: 2022-08-03 |
Sponsor Name:Amsterdam UMC, location VUmc | ||
Full Title: Precision psychiatry: Anti-inflammatory medication in Immuno-metabolic depression | ||
Medical condition: Immuno metabolic Depression | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2012-002692-34 | Sponsor Protocol Number: MitoFibrateCT1-2012 | Start Date*: 2013-06-26 |
Sponsor Name:Univ.-Klinik für Kinder- und Jugendheilkunde | ||
Full Title: Clinical study for the assessment of safety and efficacy of Bezafibrate as a drug therapy for patients with mitochondrial myopathies | ||
Medical condition: mitochondrial disorder | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-004631-77 | Sponsor Protocol Number: EX21102013 | Start Date*: 2014-01-24 |
Sponsor Name:Medizinische Universität Graz/Endokrinologie und Stoffwechsel | ||
Full Title: Exercise and Blood Glucose Levels in Patients with Type I Diabetes - a Pilot Study | ||
Medical condition: Type 1 diabetes | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-005112-42 | Sponsor Protocol Number: C14-62 | Start Date*: 2015-06-22 | |||||||||||
Sponsor Name:INSERM | |||||||||||||
Full Title: A comparative phase2 study assessing the efficacy of triheptanoin, an anaplerotic therapy in Huntington's Disease (TRIHEP 3) | |||||||||||||
Medical condition: Huntington's disease | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-000778-46 | Sponsor Protocol Number: LiBiDi-EK314/11 | Start Date*: 2013-01-17 | ||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Forschungszentrum Jülich GmbH | ||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: Elucidation of Lithium Working Mechanism in Bipolar Disorder by means of Multi Modal Brain Imaging (LiBiDi) | ||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Healthy volunteers Bipolar patients type 1 | ||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: DE (Ongoing) | ||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-003279-41 | Sponsor Protocol Number: PSY-NIL-0013 | Start Date*: 2023-03-31 |
Sponsor Name:Medical University of Vienna, University Department of Psychiatry and Psychotherapy | ||
Full Title: Investigating N-methyl-d-aspartate (NMDA) receptor alterations in major depressive disorder by brain PET | ||
Medical condition: Major Depression | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: AT (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2012-004132-33 | Sponsor Protocol Number: D1050304 | Start Date*: 2013-05-02 | |||||||||||
Sponsor Name:Sunovion Pharmaceuticals Inc. | |||||||||||||
Full Title: A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone for the Treatment of Major Depressive Disorder with Mixed Features (Protocol No D1050304) | |||||||||||||
Medical condition: Major Depressive Disorder (MDD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-003400-11 | Sponsor Protocol Number: SND103288 | Start Date*: 2005-11-09 |
Sponsor Name:GlaxoSmithKline Research & Development Ltd | ||
Full Title: An Eight-week, Multicenter, Randomized, Double-Blind, Placebo and Active-Controlled, Parallel Group, Fixed-Dose Study Evaluating the Efficacy, Safety, and Tolerability of GSK372475 (1.0 mg/day) or ... | ||
Medical condition: Major Depressive Disorder (MDD) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Prematurely Ended) EE (Prematurely Ended) DE (Completed) IT (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-002940-86 | Sponsor Protocol Number: SELLIFA-02 | Start Date*: 2007-08-24 | |||||||||||
Sponsor Name:Cliniques Universitaires Saint-Luc – Université catholique de Louvain | |||||||||||||
Full Title: Sepsis, Endothelial function, and Lipids in critically ill patients with Liver Failure (SELLIFA). Nutritional sub-study : Randomized controlled trial comparing the tolerance on lipid metabolism and... | |||||||||||||
Medical condition: Liver failure, Liver cirrhosis, critical illness, total nutritional support | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-002513-11 | Sponsor Protocol Number: 331-10-230 | Start Date*: 2012-01-09 | |||||||||||
Sponsor Name:Otsuka Pharmaceutical Development & Commercialization, Inc. | |||||||||||||
Full Title: A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Fixed dose OPC-34712 (4, 2, and 1 mg/day) in the Treatment of Adults With Acute Schizophrenia | |||||||||||||
Medical condition: Acute Schizophrenia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: SK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-002538-38 | Sponsor Protocol Number: 331-10-231 | Start Date*: 2011-10-14 | |||||||||||
Sponsor Name:Otsuka Pharmaceutical Development & Commercialization, Inc. | |||||||||||||
Full Title: A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Three Fixed Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia | |||||||||||||
Medical condition: Acute Schizophrenia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: LV (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-000574-40 | Sponsor Protocol Number: PSP-CoQ10 | Start Date*: 2006-04-24 |
Sponsor Name:Kompetenznetz Parkinson e.V. | ||
Full Title: Brain Energy Metabolism in Progressive Supranuclear Palsy: Comparison of PSP Patients and Healthy Controls and Effect of Coenzyme Q10 – nanoQuinon® | ||
Medical condition: PSP is a sporadic neurodegenerative disorder resulting in a Parkinson syndrome with postural instability, oculomotor deficits, and cognitive decline. With an average annual incidence of 5.3 / 10... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-023576-10 | Sponsor Protocol Number: CL3-20098-083 | Start Date*: 2011-06-06 | |||||||||||
Sponsor Name:Institut de Recherches Internationales Servier | |||||||||||||
Full Title: Early effect of agomelatine on general interest in outpatients with Major Depressive Disorder. A 12-week, randomized, double-blind, multicentre study with parallel groups: agomelatine (25mg/day giv... | |||||||||||||
Medical condition: Major Depressive Disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: RO (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-005325-67 | Sponsor Protocol Number: 1239102 | Start Date*: 2013-04-30 | |||||||||||
Sponsor Name:Centre Hospitalier de Toulouse | |||||||||||||
Full Title: Evaluation of tolerance, suckling and food intake after repeated nasals administrations of Oxytocin in PWS infants | |||||||||||||
Medical condition: Prader Willi Syndrom | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-002142-38 | Sponsor Protocol Number: 292008 | Start Date*: 2009-02-16 |
Sponsor Name:NV Organon | ||
Full Title: A phase I, single center, open-label parallel group trial to compare the pharmacokinetics of NOMAC between healthy female adolescents (aged 14-17 years) and healthy female adults (aged 18-50 years)... | ||
Medical condition: Hormonal oral contraception in healthy women | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-003418-15 | Sponsor Protocol Number: SSP | Start Date*: 2012-10-23 |
Sponsor Name:Medizinische Universität Wien | ||
Full Title: Methylphenidate modified release as treatment option of MS-associated fatigue. A single-center randomized double-blind placebo-controlled trial. | ||
Medical condition: Fatigue is a very common symptom in multiple sclerosis. Its management comprises nonpharmacologic approaches like exercise, cooling procedures and energy conservation programs and as second step ph... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2011-002547-94 | Sponsor Protocol Number: 2011-420 | Start Date*: 2013-03-25 | ||||||||||||||||
Sponsor Name:Dept. of Intensive Care 4131, Rigshospitalet | ||||||||||||||||||
Full Title: Early Goal-Directed Nutrition in ICU Patients – EAT-ICU Trial | ||||||||||||||||||
Medical condition: Acutely admitted, mechanically ventilated intensive care unit patients. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2021-002528-18 | Sponsor Protocol Number: RESCUE2131PE9 | Start Date*: 2022-02-22 | |||||||||||
Sponsor Name:Copenhagen University Hospital Rigshospitalet | |||||||||||||
Full Title: RESCUE - Effect of supplemental hydrocortisone during stress in prednisolone-induced adrenal insufficiency; A multicentre, randomised, double blinded, placebo-controlled clinical trial on health-re... | |||||||||||||
Medical condition: Glucocorticoid-induced adrenal insufficiency | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-002514-37 | Sponsor Protocol Number: 331-10-237 | Start Date*: 2011-10-14 | |||||||||||
Sponsor Name:Otsuka Pharmaceutical Development & Commercialization, Inc. | |||||||||||||
Full Title: A Long-term, Phase 3, Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Oral OPC-34712 as Maintenance Treatment in Adults with Schizophrenia | |||||||||||||
Medical condition: Acute Schizophrenia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: LV (Completed) PL (Completed) SK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-004972-74 | Sponsor Protocol Number: 20160227 | Start Date*: 2020-09-15 | |||||||||||
Sponsor Name:Amgen Inc. | |||||||||||||
Full Title: An Open-label, Ascending Multiple dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Romosozumab in Children and Adolescents With Osteogenesis Imperfecta | |||||||||||||
Medical condition: Osteogenesis imperfecta (OI) is a group of genetic skeletal disorders characterized by increased bone fragility, low bone mass , and increased bone turnover contributing to osteoporosis, fracture... | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) DE (Completed) GR (Completed) IT (Completed) AT (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
